• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植术后早期血浆 ddcfDNA 水平的动态变化:一项单中心的初步研究。

Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study.

机构信息

Kidney Disease Center, The First Affiliated Hospital of Zhejiang University, Hangzhou, China.

Zhejiang University Institute of Nephrology, Hangzhou, China.

出版信息

Transpl Int. 2019 Feb;32(2):184-192. doi: 10.1111/tri.13341. Epub 2018 Oct 2.

DOI:10.1111/tri.13341
PMID:30198148
Abstract

Donor-derived cell-free DNA (ddcfDNA) is reported to be a promising noninvasive biomarker for acute rejection in organ transplant. However, studies on monitoring ddcfDNA dynamics during the early periods after organ transplantation are scarce. Our study assessed the dynamic variation in ddcfDNA in early period with various types and status of kidney transplantation. Target region capture sequencing used identifies ddcfDNA level in 21 kidney transplant recipients. Median ddcfDNA level was 20.69% at the initial time post-transplant, and decreased to 5.22% on the first day and stayed at the stable level after the second day. The ddcfDNA level in DCD (deceased donors) group (44.99%) was significantly higher than that in LDRT (living donor) group (10.24%) at initial time, P < 0.01. DdcfDNA level in DGF (delayed graft function) recipients was lower (23.96%) than that in non-DGF (47.74%) at the initial time, P = 0.89 (19.34% in DGF and 4.46% in non-DGF on the first day, P = 0.17). DdcfDNA level at initial time significantly correlated with serum creatinine (r  = 0.219, P = 0.032) and warm ischemia time (r  = 0.204, P = 0.040). Plasma ddcfDNA level decreased rapidly follow an L-shaped curve post-transplant, and level in DGF declined slower than non-DGF. The rebound of ddcfDNA level may indicate the occurrence of acute rejection.

摘要

供体来源的无细胞 DNA(ddcfDNA)被报道为器官移植中急性排斥反应的一种很有前途的非侵入性生物标志物。然而,关于器官移植后早期监测 ddcfDNA 动态变化的研究很少。我们的研究评估了不同类型和状态的肾移植后早期 ddcfDNA 的动态变化。目标区域捕获测序用于确定 21 名肾移植受者的 ddcfDNA 水平。移植后初始时间的中位数 ddcfDNA 水平为 20.69%,第 1 天降至 5.22%,第 2 天稳定。初始时,DCD(已故供体)组的 ddcfDNA 水平(44.99%)明显高于 LDRT(活体供体)组(10.24%),P<0.01。DGF(移植肾功能延迟恢复)受者的 ddcfDNA 水平(23.96%)低于非 DGF(47.74%),P=0.89(DGF 为 19.34%,非 DGF 为 4.46%,第 1 天,P=0.17)。初始时的 ddcfDNA 水平与血清肌酐呈显著相关(r=0.219,P=0.032)和热缺血时间(r=0.204,P=0.040)。移植后,ddcfDNA 水平迅速下降呈 L 形曲线,DGF 水平下降速度比非 DGF 慢。ddcfDNA 水平的反弹可能表明急性排斥反应的发生。

相似文献

1
Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study.肾移植术后早期血浆 ddcfDNA 水平的动态变化:一项单中心的初步研究。
Transpl Int. 2019 Feb;32(2):184-192. doi: 10.1111/tri.13341. Epub 2018 Oct 2.
2
The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.使用血浆供体来源的无细胞 DNA 监测肾移植后的急性排斥反应。
Nephrol Dial Transplant. 2020 Apr 1;35(4):714-721. doi: 10.1093/ndt/gfz091.
3
Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function.移植后供体游离 DNA 的早期动力学可预测肾移植物的恢复和长期功能。
Nephrol Dial Transplant. 2023 Dec 20;39(1):114-121. doi: 10.1093/ndt/gfad120.
4
Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.早期和晚期肾移植功能障碍生物标志物的最新进展。
Int J Mol Sci. 2020 Jul 29;21(15):5404. doi: 10.3390/ijms21155404.
5
The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation.供者游离 DNA 监测在肾移植中的应用
Transplantation. 2021 Mar 1;105(3):509-516. doi: 10.1097/TP.0000000000003393.
6
Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay.采用单管多重 PCR 检测方法研究肾移植后供者来源的无细胞 DNA 动力学。
PLoS One. 2018 Dec 6;13(12):e0208207. doi: 10.1371/journal.pone.0208207. eCollection 2018.
7
The impact of kidney donor profile index on delayed graft function and transplant outcomes: A single-center analysis.肾移植供者特征指数对移植肾功能延迟恢复及移植结局的影响:单中心分析。
Clin Transplant. 2018 Mar;32(3):e13190. doi: 10.1111/ctr.13190.
8
Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.将严谨性和可重复性标准应用于检测供体无细胞游离 DNA,作为心脏移植后急性排斥反应和移植物损伤的非侵入性检测方法。
J Heart Lung Transplant. 2017 Sep;36(9):1004-1012. doi: 10.1016/j.healun.2017.05.026. Epub 2017 May 20.
9
Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes.心脏死亡后捐献者的肾脏移植:移植后结局不受延迟移植物功能的影响。
Clin Transplant. 2011 Mar-Apr;25(2):255-64. doi: 10.1111/j.1399-0012.2010.01241.x.
10
Donor-derived cell-free DNA: An independent biomarker in kidney transplant patients with antibody-mediated rejection.供者游离 DNA:抗体介导排斥反应的肾移植患者的独立生物标志物。
Transpl Immunol. 2021 Dec;69:101404. doi: 10.1016/j.trim.2021.101404. Epub 2021 May 8.

引用本文的文献

1
Advances and challenges in the application of donor-derived cell-free DNA for diagnosis and treatment in liver transplantation: a narrative review.供体来源的游离DNA在肝移植诊断和治疗中的应用进展与挑战:一篇叙述性综述
BMC Surg. 2025 May 13;25(1):203. doi: 10.1186/s12893-025-02911-y.
2
Clinical use of donor-derived cell-free DNA in kidney transplantation.供体来源的游离DNA在肾移植中的临床应用。
World J Transplant. 2024 Dec 18;14(4):97219. doi: 10.5500/wjt.v14.i4.97219.
3
Current and emerging tools for simultaneous assessment of infection and rejection risk in transplantation.
用于同时评估移植中感染和排斥风险的现有及新兴工具。
Front Immunol. 2024 Nov 26;15:1490472. doi: 10.3389/fimmu.2024.1490472. eCollection 2024.
4
A review of cell-free DNA and epigenetics for non-invasive diagnosis in solid organ transplantation.实体器官移植中用于无创诊断的游离DNA与表观遗传学综述
Front Transplant. 2024 Nov 15;3:1474920. doi: 10.3389/frtra.2024.1474920. eCollection 2024.
5
Graft-derived cell free DNA: used for assessment of early graft status and its implications for long-term kidney function.移植来源的游离DNA:用于评估早期移植状态及其对长期肾功能的影响。
Front Physiol. 2024 Nov 15;15:1440799. doi: 10.3389/fphys.2024.1440799. eCollection 2024.
6
Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejection.基于供体游离DNA的液体活检用于确定未来肾移植排斥反应。
Kidney Res Clin Pract. 2025 Sep;44(5):705-725. doi: 10.23876/j.krcp.23.286. Epub 2024 Sep 13.
7
Analysis of the primary factors influencing donor derived cell-free DNA testing in kidney transplantation.分析影响肾移植中供体游离 DNA 检测的主要因素。
Front Immunol. 2024 Sep 6;15:1435578. doi: 10.3389/fimmu.2024.1435578. eCollection 2024.
8
Single center study investigating the clinical association of donor-derived cell-free DNA with acute outcomes in lung transplantation.一项单中心研究,旨在探究供体来源的游离DNA与肺移植急性结局之间的临床关联。
Front Transplant. 2024 Jan 11;2:1339814. doi: 10.3389/frtra.2023.1339814. eCollection 2023.
9
Cell-Free Mitochondrial DNA: An Upcoming Non-Invasive Tool for Diagnosis of BK Polyomavirus-Associated Nephropathy.无细胞线粒体 DNA:一种用于诊断 BK 多瘤病毒相关性肾病的新型非侵入性工具。
Biomolecules. 2024 Mar 14;14(3):348. doi: 10.3390/biom14030348.
10
Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population.供体来源的游离DNA作为肾移植受者移植排斥反应的非侵入性生物标志物:印度人群中的一项前瞻性研究。
Diagnostics (Basel). 2023 Nov 27;13(23):3540. doi: 10.3390/diagnostics13233540.